Interestingly, the results demonstrated that, with the exception of TGFB1, the DNA methylation levels of the CpG sites in the other five biomarker candidates in tumor tissues were significantly lower in HNSCC tissues (Figure 6A). The gene discussed is TGFB1; the disease is neoplasm.